Startups

Inventory Control Manager, Supply Chain (Contractor)

Centessa Pharmaceuticals · Boston, MA · On-site

← All jobs
About Centessa Pharmaceuticals

Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders.... Backed by Foresite Capital.

About the role

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor's degree in supply chain, science, engineering, or a related field required
  • 3–5 years of biotech/pharma industry experience in supply chain, inventory management, or clinical supply, including experience working with external vendors, required
  • Working knowledge of GMP/GDP requirements and inventory management practices in a regulated environment
  • Experience using an ERP, IRT, or other logistics/inventory management information system, or demonstrated ability to learn new systems quickly
  • Demonstrated success managing detailed data sets and inventory records with a high degree of accuracy
  • Experience coordinating with CMOs, 3PLs, or other external vendors on day-to-day logistics and inventory matters
More about this role

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.

Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work ® in 2026.

Centessa is seeking an Inventory Manager, Supply Chain contractor to own inventory planning, control, and reconciliation across the company's outsourced clinical supply network, including investigational product (IP), comparators, and ancillary materials held at third-party depots, CMOs/CDMOs, and distribution partners. This role ensures accurate , real-time visibility into inventory levels, drives forecast accuracy, and partners closely with external vendors and...

Read the full posting on Centessa Pharmaceuticals's site ↗

CMC

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.